Navigation For Mobile
  2. >
  3. 2013
  4. >
  5. January

Monthly Archives: January 2013

API Manufacture: Identifying & Controlling Genotoxic Impurities

Posted on January 28, 2013 by

Since API manufacturing plays a critical role during clinical development and after approval of a drug, familiarity with genotoxic impurities is an important issue for pharmaceutical firms considering outsourced API…

Posted in APIs, Congtract Manufacturing, genotoxic impurities | Comments Off on API Manufacture: Identifying & Controlling Genotoxic Impurities